BCAB
BioAtla, Inc.
NASDAQ · Healthcare · Biotechnology · US
$1.74
+2.66%Margins
Gross margin
-4.2%
EBITDA margin
-343.2%
EBIT margin
-372.1%
Net margin
-370.0%
FCF margin
-276.3%
86.8%
Return on equity
-330.9%
Return on assets
104.1%
Return on invested capital
0.94x
Asset turnover
-$23.5M
Cash from operations
$0.93
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026